GlassScriptPhysician profile
Ronald D Ford
NPI 1558310912
$4,541.38
in general payments reported to CMS, 2019-2025
21 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $42.36 · 2021: $629 · 2022: $741 · 2023: $768 · 2024: $1,300 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,640 · Travel and Lodging: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,640.42 |
| Travel and Lodging | $153.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,149.26 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $772.17 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $354.23 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Tela Bio, INC. | $257.53 | 2022-2024 | Ovitex 2s |
| Depuy Synthes Sales INC. | $255.13 | 2021-2022 | |
| Allergan, INC. | $252.46 | 2019-2021 | |
| Galderma Laboratories, L.P. | $227.06 | 2019-2022 | |
| Stryker Corporation | $198.77 | 2024-2025 | Smartlock, Na, Vsp System, Vsp Cranial |
| Polynovo North America LLC | $170.35 | 2024 | Novosorb Btm |
| Mesh Suture INC | $142.14 | 2025 | |
| Davol INC. | $131.84 | 2023 | Phasix Mesh |
| Abbvie INC. | $124.99 | 2023 | |
| Sientra, INC. | $123.46 | 2021-2022 | |
| Checkpoint Surgical, INC | $120.77 | 2022 | |
| W. L. Gore & Associates, INC. | $61.29 | 2024 | Product In Development |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $52.31 | 2023 | Puraply |
| Aroa Biosurgery Incorporated | $47.07 | 2025 | |
| Axogen | $34.85 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Solventum Corporation | $26.37 | 2025 | V.A.C. Veraflo, Prevena |
| Bioventus LLC | $20.27 | 2022 | |
| Medwest Associates | $19.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.